Treatment Strategies for Residual Disease following Neoadjuvant Chemotherapy in Patients with Early-Stage Breast Cancer.

Breast cancer continues to be the most diagnosed cancer among women worldwide. Neoadjuvant chemotherapy is the standard of care for breast cancer patients with locally advanced disease and patients with poor pathological features, such as triple-negative (TN) or human epidermal growth factor recepto...

Full description

Bibliographic Details

Published in:	Current Oncology Vol. 29; no. 8; pp. 5810 - 5823
Main Authors:	Abdel-Razeq, Hikmat, Khalil, Hanan, Assi, Hazem I., Dargham, Tarek Bou
Format:	Journal Article
Published:	MDPI Aug2022
Online Access:	View this record in EBSCOhost